Comprehensive mass spectrometry based biomarker discovery and validation platform as applied to diabetic kidney disease
A protein biomarker discovery workflow was applied to plasma samples from patients at different stages of diabetic kidney disease. The proteomics platform produced a panel of significant plasma biomarkers that were statistically scrutinised against the current gold standard tests on an analysis of 5...
| Hlavní autoři: | , , , , , , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Elsevier
2017-03-01
|
| Edice: | EuPA Open Proteomics |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2212968516300393 |